On Monday, Pliant Therapeutics Inc (NASDAQ: PLRX) was 5.79% up from the session before settling in for the closing price of $1.21. A 52-week range for PLRX has been $1.10 – $15.27.
Healthcare Sector giant saw their annual sales slid by -78.30% over the last five years. When this article was written, the company’s average yearly earnings per share was at 29.82%. With a float of $57.00 million, this company’s outstanding shares have now reached $61.45 million.
Pliant Therapeutics Inc (PLRX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Pliant Therapeutics Inc stocks. The insider ownership of Pliant Therapeutics Inc is 7.24%, while institutional ownership is 77.31%. The most recent insider transaction that took place on Jan 17 ’25, was worth 587,150. In this transaction President and CEO of this company sold 52,419 shares at a rate of $11.20, taking the stock ownership to the 430,517 shares. Before that another transaction happened on Jan 17 ’25, when Company’s Chief Financial Officer sold 20,148 for $11.20, making the entire transaction worth $225,680. This insider now owns 262,608 shares in total.
Pliant Therapeutics Inc (PLRX) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.82 earnings per share (EPS) during the time that was better than consensus figure (set at -0.96) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.69% during the next five years compared to -78.30% drop over the previous five years of trading.
Pliant Therapeutics Inc (NASDAQ: PLRX) Trading Performance Indicators
You can see what Pliant Therapeutics Inc (PLRX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.87, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.90 in one year’s time.
Technical Analysis of Pliant Therapeutics Inc (PLRX)
Analysing the last 5-days average volume posted by the [Pliant Therapeutics Inc, PLRX], we can find that recorded value of 4.79 million was better than the volume posted last year of 1.5 million. As of the previous 9 days, the stock’s Stochastic %D was 22.44%.
During the past 100 days, Pliant Therapeutics Inc’s (PLRX) raw stochastic average was set at 16.25%, which indicates a significant decrease from 25.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1299 in the past 14 days, which was higher than the 0.1144 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5864, while its 200-day Moving Average is $1.5485. Now, the first resistance to watch is $1.3300. This is followed by the second major resistance level at $1.3800. The third major resistance level sits at $1.4600. If the price goes on to break the first support level at $1.2000, it is likely to go to the next support level at $1.1200. Now, if the price goes above the second support level, the third support stands at $1.0700.
Pliant Therapeutics Inc (NASDAQ: PLRX) Key Stats
There are 61,449K outstanding shares of the company, which has a market capitalization of 78.66 million. As of now, sales total 0 K while income totals -210,300 K. Its latest quarter income was 0 K while its last quarter net income were -26,300 K.
